| ASSET | QUARTER | % RETURN |
|---|---|---|
QXO (QXO) | Q2 2005 | 350% |
Vertex Pharmaceuticals (VRTX) | Q2 2005 | 80.99% |
Nasdaq (NDAQ) | Q2 2005 | 71.77% |
Regeneron Pharmaceuticals (REGN) | Q2 2005 | 64.19% |
Alphabet Inc Class A (GOOGL) | Q2 2005 | 61.84% |
CME (CME) | Q2 2005 | 53.31% |
Biomarin Pharmaceutical (BMRN) | Q2 2005 | 51.42% |
Netflix (NFLX) | Q2 2005 | 50.55% |
Corning (GLW) | Q2 2005 | 48.26% |
Illumina (ILMN) | Q2 2005 | 47.92% |
Salesforce (CRM) | Q2 2005 | 40.76% |
Monster Beverage (MNST) | Q2 2005 | 39.66% |
Trip Group Ltd ADR (TCOM) | Q2 2005 | 34.26% |
Banco Bradesco SA ADR (BBD) | Q2 2005 | 31.37% |
Best Buy (BBY) | Q2 2005 | 31.08% |
Vicor (VICR) | Q2 2005 | 30.64% |
Tenaris SA ADR (TS) | Q2 2005 | 29.85% |
James Hardie Industries PLC ADR (JHX) | Q2 2005 | 27.98% |
Toll Brothers (TOL) | Q2 2005 | 26.23% |
Canadian Natural Resources (CNQ) | Q2 2005 | 25.63% |
CBRE Group Inc Class A (CBRE) | Q2 2005 | 25.31% |
HF Sinclair (DINO) | Q2 2005 | 24.67% |
DR Horton (DHI) | Q2 2005 | 23.68% |
Humana (HUM) | Q2 2005 | 23.61% |
Martin Marietta Materials (MLM) | Q2 2005 | 23.5% |
Large-cap stocks are treated as having a market cap of $10B+.